Rybodyn
Other AI Category
· Headquartered in United States 🇺🇸
Track Rybodyn
— get Other AI Category deals in free daily digest
Overview
RyboDyn, a biotechnology company based in San Diego, has raised $10 million in seed funding to advance its AI-powered cancer target discovery platform. The funding will help transition the company from foundational discovery to scaled execution, focusing on uncovering cryptic proteins from non-canonical RNA to identify new cancer targets. RyboDyn's platform has expanded the discovery of novel RNA species and identified over 80,000 cryptic peptides, aiming to address bottlenecks in oncology drug development.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
RyboDyn, a biotechnology company based in San Diego, has raised $10 million in seed funding to advance its AI-powered cancer target discovery platform. The funding will help transition the company from foundational discovery to scaled execution, focusing on uncovering cryptic proteins from non-canonical RNA to identify new cancer targets. RyboDyn's platform has expanded the discovery of novel RNA species and identified over 80,000 cryptic peptides, aiming to address bottlenecks in oncology drug development.
More Other AI Category Deals
Market Map
View thousands of companies by category in our market map:
